Low-grade non-hodgkin lymphomas. Semin Radiat Oncol 2007; 17: 198-205.Tsang RW, Gospodarowicz MK. Low-grade non-Hodgkin lymphomas. Semin Radiat Oncol 2007;17:198–205.Richard W. Tsang, Mary K. Gospodarowicz. (2007) Low-Grade Non-Hodgkin Lymphomas. Seminars in Radiation Oncology 17 , 198...
Long term survival among patients (pts) with low grade/indolent Non-Hodgkin lymphoma (iNHL) is increasingly common, and as a consequence, a consideration of potential therapy-related sequelae, such as secondary neoplasia (sNPL), is of particular importance. Bendamustine plus rituximab (B-R) is ...
June 22, 2005 (Toronto) — Long-term follow-up of patients with low-grade non–Hodgkin's lymphoma (NHL) shows that a single treatment with tositumomab and iodine I-131 tositumomab (the Bexxar regimen) can result in prolonged remission, according to research presented here at the Society for ...
Haas, R., Moos, M., Karcher, A., Mohle, R., Witt, B., Goldschmidt, H., Fruhauf, S., Flentje, M., Wannenmacher, M. and Hunstein, W. (1994) Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin’s lymphoma.Journal of Clinical Oncology...
into Cancer and nutrition (n = 261) and in the Northern Sweden Health and Disease Study (n = 402), we tested the hypothesis that an inflammatory score is associated with breast cancer (BC) and Β-cell Non-Hodgkin Lymphoma (B-cell NHL, including 68 multiple myeloma cases) onset...
SAN DIEGO-There have been no reported cases of treatment-related myelodysplastic syndrome and acute myeloblastic leukemia (tMDS/tAML) in patients with low-grade non-Hodgkin’s lymphoma (NHL) treated initially with the Bexxar therapeutic regimen (tositumo
Wepresentararecaseofthedevelopmentoflowgrade non-Hodgkinlymphoma(NHL)inthemastoidboneina patientwithanatypicalCogan’ssyndromewithout progressionofNHLandwithsymptomaticdeteriorationof Cogan’ssyndrome,respondingonlytoTNF-amodulation. Casepresentation A67yearoldfemaleCaucasianpatientfromGreecepresented ...
Benz, R., Viecelli, A., Taverna, C.et al.Paroxysmal non-kinesigenic dyskinesia due to spinal cord infiltration of low-grade B cell non-Hodgkin's lymphoma.Ann Hematol91, 463–465 (2012). https://doi.org/10.1007/s00277-011-1258-4 ...
Rituximab, a chimeric antibody that targets CD20+ B cells, produces a 48% response rate in patients with refractory low-grade non-Hodgkin lymphoma. In this phase II trial, patients with low-grade non-Hodgkin lymphoma who had previously received no systemic therapy were treated with rituximab, 37...
low-grade infection low-grade infection low-grade infection Low-Grade Intraepithelial Lesion Low-Grade Intraepithelial Neoplasia low-grade lymphoma Low-Grade Moron Low-Grade Non-Hodgkin's Lymphoma low-grade papillary carcinoma of palate Low-Grade Squamous Intraepithelial Lesion ...